{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:54:58Z","timestamp":1781819698737,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Von Hippel-Lindau (VHL) disease is an autosomal-dominantly inherited tumor predisposition syndrome. One of the most common tumors are central nervous system (CNS) hemangioblastomas. Recommendations on the initiation and continuation of the screening and surveillance program for CNS tumors in pediatric VHL patients are based on small case series and thus low evidence level. To derive more robust screening recommendations, we report on the largest monocentric pediatric cohort of VHL patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a retrospective analysis on a pediatric cohort of 99 VHL patients consulted at our VHL center from 1992 to 2023. Clinical, surgical, genetic, and imaging data were collected and statistically analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>42 patients (50% male) developed CNS hemangioblastomas, of whom 18 patients (56% male) underwent hemangioblastoma surgery (mean age at first surgery: 14.9\u2009\u00b1\u20091.9 years; range 10.2\u201317). The first asymptomatic patient was operated on at the age of 13.2 years due to tumor progress. Truncating <jats:italic>VHL<\/jats:italic> mutation carriers had a significantly higher manifestation rate (HR\u2009=\u20093.7, 95% CI: 1.9\u20137.4, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) and surgery rate (HR\u2009=\u20093.3, 95% CI: 1.2\u20138.9, <jats:italic>p<\/jats:italic>\u2009=\u20090.02) compared with missense mutation carriers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We recommend starting MRI imaging at the age of 12 years with examination intervals every (1-) 2 years depending on CNS involvement. Special attention should be paid to patients with truncating variants. Affected families should be educated regularly on potential tumor-associated symptoms to enable timely MRI imaging and eventually intervention, as CNS hemangioblastoma may develop before screening begins.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>German clinical trials Register registration number<\/jats:title>\n                <jats:p>DRKS00029553, date of registration 08\/16\/2022, retrospectively registered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11060-024-04676-5","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T15:01:51Z","timestamp":1713798111000},"page":"537-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease"],"prefix":"10.1007","volume":"168","author":[{"given":"Anna Laura","family":"Knoblauch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.-I.","family":"Bla\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Steiert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Neidert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Puzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Neumann-Haefelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ganner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kotsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.P.H.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Elsheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-H.","family":"Klingler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"issue":"283","key":"4676_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","volume":"77","author":"ER Maher","year":"1990","unstructured":"Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA (1990) Clinical features and natural history of Von Hippel-Lindau disease. Q J Med 77(283):1151\u20131163. https:\/\/doi.org\/10.1093\/qjmed\/77.2.1151","journal-title":"Q J Med"},{"issue":"6","key":"4676_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher ER, Neumann HP, Richard S (2011) Von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet 19(6):617\u2013623. https:\/\/doi.org\/10.1038\/ejhg.2010.175","journal-title":"Eur J Hum Genet"},{"issue":"9374","key":"4676_CR3","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn G, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (2003) Von Hippel-Lindau disease. Lancet 361(9374):2059\u20132067. https:\/\/doi.org\/10.1016\/S0140-6736(03)13643-4","journal-title":"Lancet"},{"issue":"5112","key":"4676_CR4","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L (1993) Identification of the Von Hippel-Lindau disease tumor suppressor gene. Science 260(5112):1317\u20131320. https:\/\/doi.org\/10.1126\/science.8493574","journal-title":"Science"},{"issue":"1","key":"4676_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/gim.2015.44","volume":"18","author":"ML Binderup","year":"2016","unstructured":"Binderup ML, Budtz-Jorgensen E, Bisgaard ML (2016) Risk of new tumors in Von Hippel-Lindau patients depends on age and genotype. Genet Med 18(1):89\u201397. https:\/\/doi.org\/10.1038\/gim.2015.44","journal-title":"Genet Med"},{"key":"4676_CR6","unstructured":"The VHL, Alliance (2020) The VHL Handbook 6. Edition"},{"issue":"7","key":"4676_CR7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/neuonc\/nov313","volume":"18","author":"A Feletti","year":"2016","unstructured":"Feletti A, Anglani M, Scarpa B, Schiavi F, Boaretto F, Zovato S, Taschin E, Gardi M, Zanoletti E, Piermarocchi S, Murgia A, Pavesi G, Opocher G (2016) Von Hippel-Lindau disease: an evaluation of natural history and functional disability. Neuro Oncol 18(7):1011\u20131020. https:\/\/doi.org\/10.1093\/neuonc\/nov313","journal-title":"Neuro Oncol"},{"key":"4676_CR8","doi-asserted-by":"publisher","first-page":"106281","DOI":"10.1016\/j.clineuro.2020.106281","volume":"199","author":"Q Wang","year":"2020","unstructured":"Wang Q, Meng S, Cheng J, Zhang S, Ju Y, Fang Y, Zhang Y, Huang S, Liu W, Hui X (2020) Central nervous system hemangioblastomas: an age-stratified analysis. Clin Neurol Neurosurg 199:106281. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106281","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"4676_CR9","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1007\/s00381-020-04712-5","volume":"36","author":"JH Klingler","year":"2020","unstructured":"Klingler JH, Gl\u00e4sker S, Bausch B, Urbach H, Krauss T, Jilg CA, Steiert C, Puzik A, Neumann-Haefelin E, Kotsis F, Agostini H, Neumann HPH, Beck J (2020) Hemangioblastoma and Von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment. Childs Nerv Syst 36(10):2537\u20132552. https:\/\/doi.org\/10.1007\/s00381-020-04712-5","journal-title":"Childs Nerv Syst"},{"issue":"9","key":"4676_CR10","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1002\/ajmg.a.38324","volume":"173","author":"K Launbjerg","year":"2017","unstructured":"Launbjerg K, Bache I, Galanakis M, Bisgaard ML, Binderup MLM (2017) Von Hippel-Lindau development in children and adolescents. Am J Med Genet A 173(9):2381\u20132394. https:\/\/doi.org\/10.1002\/ajmg.a.38324","journal-title":"Am J Med Genet A"},{"issue":"5","key":"4676_CR11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3171\/2014.1.JNS131431","volume":"120","author":"RR Lonser","year":"2014","unstructured":"Lonser RR, Butman JA, Huntoon K, Asthagiri AR, Wu T, Bakhtian KD, Chew EY, Zhuang Z, Linehan WM, Oldfield EH (2014) Prospective natural history study of central nervous system hemangioblastomas in Von Hippel-Lindau disease. J Neurosurg 120(5):1055\u20131062. https:\/\/doi.org\/10.3171\/2014.1.JNS131431","journal-title":"J Neurosurg"},{"issue":"5","key":"4676_CR12","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1001\/jamaneurol.2017.4469","volume":"75","author":"D Dornbos 3rd","year":"2018","unstructured":"Dornbos D 3rd, Kim HJ, Butman JA, Lonser RR (2018) Review of the neurological implications of Von Hippel-Lindau Disease. JAMA Neurol 75(5):620\u2013627. https:\/\/doi.org\/10.1001\/jamaneurol.2017.4469","journal-title":"JAMA Neurol"},{"issue":"2","key":"4676_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3171\/jns.2006.105.2.248","volume":"105","author":"JM Ammerman","year":"2006","unstructured":"Ammerman JM, Lonser RR, Dambrosia J, Butman JA, Oldfield EH (2006) Long-term natural history of hemangioblastomas in patients with Von Hippel-Lindau disease: implications for treatment. J Neurosurg 105(2):248\u2013255. https:\/\/doi.org\/10.3171\/jns.2006.105.2.248","journal-title":"J Neurosurg"},{"issue":"8","key":"4676_CR14","doi-asserted-by":"publisher","first-page":"104538","DOI":"10.1016\/j.ejmg.2022.104538","volume":"65","author":"M Louise","year":"2022","unstructured":"Louise M, Binderup M, Smerdel M, Borgwadt L et al (2022) Von Hippel-Lindau disease: updated guideline for diagnosis and surveillance. Eur J Med Genet 65(8):104538. https:\/\/doi.org\/10.1016\/j.ejmg.2022.104538","journal-title":"Eur J Med Genet"},{"issue":"6","key":"4676_CR15","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3171\/2021.3.JNS204203","volume":"136","author":"K Huntoon","year":"2021","unstructured":"Huntoon K, Shepard MJ, Lukas RV, McCutcheon IE, Daniels AB, Asthagiri AR (2021) Hemangioblastoma diagnosis and surveillance in Von Hippel-Lindau disease: a consensus statement. J Neurosurg 136(6):1511\u20131516. https:\/\/doi.org\/10.3171\/2021.3.JNS204203","journal-title":"J Neurosurg"},{"issue":"12","key":"4676_CR16","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","volume":"23","author":"SP Rednam","year":"2017","unstructured":"Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK, Nathanson KL, States LJ, Tomlinson GE, Villani A, Voss SD, Schiffman JD, Wasserman JD (2017) Von Hippel-Lindau and Hereditary Pheochromocytoma\/Paraganglioma Syndromes: clinical features, Genetics, and Surveillance recommendations in Childhood. Clin Cancer Res 23(12):e68\u2013e75. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0547","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4676_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s0300-2977(01)00165-6","volume":"59","author":"FJ Hes","year":"2001","unstructured":"Hes FJ, van der Luijt RB, Lips CJ (2001) Clinical management of Von Hippel-Lindau (VHL) disease. Neth J Med 59(5):225\u2013234. https:\/\/doi.org\/10.1016\/s0300-2977(01)00165-6","journal-title":"Neth J Med"},{"issue":"1","key":"4676_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/ERC-13-0308","volume":"21","author":"RC Kruizinga","year":"2013","unstructured":"Kruizinga RC, Sluiter WJ, de Vries EG, Zonnenberg BA, Lips CJ, van der Horst-Schrivers AN, Walenkamp AM, Links TP (2013) Calculating optimal surveillance for detection of Von Hippel-Lindau-related manifestations. Endocr Relat Cancer 21(1):63\u201371. https:\/\/doi.org\/10.1530\/ERC-13-0308","journal-title":"Endocr Relat Cancer"},{"key":"4676_CR19","doi-asserted-by":"publisher","unstructured":"Nordstrom-O\u2019Brien M, van der Luijt RB, van Rooijen E, an, den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van Brussel A, Voest EE, Giles RH (2010) Genetic analysis of von Hippel-Lindau disease. Human mutation 31(5):521\u2013537. https:\/\/doi.org\/10.1002\/humu.21219","DOI":"10.1002\/humu.21219"},{"issue":"4","key":"4676_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00004728-199207000-00004","volume":"16","author":"P Lundin","year":"1992","unstructured":"Lundin P, Pedersen F (1992) Volume of pituitary macroadenomas: assessment by MRI. J Comput Assist Tomogr 16(4):519\u2013528. https:\/\/doi.org\/10.1097\/00004728-199207000-00004","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"4676_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.14245\/ns.2244970.485","volume":"20","author":"B Han","year":"2023","unstructured":"Han B, Zhang L, Jia W (2023) Pediatric spinal hemangioblastomas: clinical features and Surgical outcomes of 39 cases. Neurospine 20(1):343\u2013352. https:\/\/doi.org\/10.14245\/ns.2244970.485","journal-title":"Neurospine"},{"issue":"5","key":"4676_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/cge.13613","volume":"96","author":"Y Salama","year":"2019","unstructured":"Salama Y, Albanyan S, Szybowska M et al (2019) Comprehensive characterization of a Canadian cohort of Von Hippel-Lindau disease patients. Clin Genet 96(5):461\u2013467. https:\/\/doi.org\/10.1111\/cge.13613","journal-title":"Clin Genet"},{"issue":"9","key":"4676_CR23","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/cam4.1134","volume":"6","author":"JY Wang","year":"2017","unstructured":"Wang JY, Peng SH, Ning XH, Li T, Liu SJ, Liu JY, Hong BA, Qi NN, Peng X, Zhou BW, Zhang JF, Cai L, Gong K (2017) Shorter telomere length increases age-related tumor risks in Von Hippel-Lindau disease patients. Cancer Med 6(9):2131\u20132141. https:\/\/doi.org\/10.1002\/cam4.1134","journal-title":"Cancer Med"},{"issue":"17","key":"4676_CR24","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0000000000002064","volume":"85","author":"ML Binderup","year":"2015","unstructured":"Binderup ML, Budtz-J\u00f8rgensen E, Bisgaard ML (2015) New Von Hippel-Lindau manifestations develop at the same or decreased rates in pregnancy. Neurology 85(17):1500\u20131503. https:\/\/doi.org\/10.1212\/WNL.0000000000002064","journal-title":"Neurology"},{"issue":"1","key":"4676_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3171\/jns.2003.98.1.0082","volume":"98","author":"JE Wanebo","year":"2003","unstructured":"Wanebo JE, Lonser RR, Glenn GM, Oldfield EH (2003) The natural history of hemangioblastomas of the central nervous system in patients with Von Hippel-Lindau disease. J Neurosurg 98(1):82\u201394. https:\/\/doi.org\/10.3171\/jns.2003.98.1.0082","journal-title":"J Neurosurg"},{"issue":"9","key":"4676_CR26","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00701-017-3275-0","volume":"159","author":"J Cheng","year":"2017","unstructured":"Cheng J, Liu W, Hui X, Zhang S, Ju Y (2017) Pediatric central nervous system hemangioblastomas: different from adult forms? A retrospective series of 25 cases. Acta Neurochir (Wien) 159(9):1603\u20131611. https:\/\/doi.org\/10.1007\/s00701-017-3275-0","journal-title":"Acta Neurochir (Wien)"},{"issue":"9","key":"4676_CR27","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00381-005-0018-y","volume":"22","author":"VI Vougioukas","year":"2006","unstructured":"Vougioukas VI, Gl\u00e4sker S, Hubbe U, Berlis A, Omran H, Neumann HP, Van Velthoven V (2006) Surgical treatment of hemangioblastomas of the central nervous system in pediatric patients. Childs Nerv Syst 22(9):1149\u20131153. https:\/\/doi.org\/10.1007\/s00381-005-0018-y","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"4676_CR28","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3171\/2015.4.JNS1533","volume":"124","author":"K Huntoon","year":"2016","unstructured":"Huntoon K, Wu T, Elder JB, Butman JA, Chew EY, Linehan WM, Oldfield EH, Lonser RR (2016) Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in Von Hippel-Lindau disease. J Neurosurg 124(4):971\u2013976. https:\/\/doi.org\/10.3171\/2015.4.JNS1533","journal-title":"J Neurosurg"},{"issue":"1","key":"4676_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-0004.2009.01281.x","volume":"77","author":"ML Poulsen","year":"2010","unstructured":"Poulsen ML, Budtz-J\u00f8rgensen E, Bisgaard ML (2010) Surveillance in Von Hippel-Lindau disease (vHL). Clin Genet 77(1):49\u201359. https:\/\/doi.org\/10.1111\/j.1399-0004.2009.01281.x","journal-title":"Clin Genet"},{"issue":"5","key":"4676_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00717-007-0222-0","volume":"21","author":"HP Neumann","year":"2007","unstructured":"Neumann HP, Cybulla M, Gl\u00e4sker S et al (2007) Von-Hippel-Lindau-Erkrankung. Interdisziplin\u00e4re Patientenversorgung [Von Hippel-Lindau disease. Interdisciplinary patient care]. Spektrum Augenheilkd 21(5):271\u2013278. https:\/\/doi.org\/10.1007\/s00717-007-0222-0","journal-title":"Spektrum Augenheilkd"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04676-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04676-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04676-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T14:05:01Z","timestamp":1718805901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04676-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["4676"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04676-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"7 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee (number: 2-1269-S1-retro).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No consent form was required for this retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"NN and JHK declare that they have received research funding from \u201cVerein VHL betroffener Familien e.V. together with Christine-Rath-Stiftung\u201d.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}